v3.26.1
Other operating income and expenses
 6 Months Ended
Jun. 30, 2026
Analysis of income and expense [abstract]  
Other operating income and expenses
B.15. Other operating income and expenses
Other operating income amounted to €800 million in the first half of 2026 (versus €533 million in the first half of 2025), and Other operating expenses to €3,436 million (versus € 2,476 million in the first half of 2025), as shown in the table below.
(€ million)
June 30, 2026 (6 months)
June 30, 2025 (6 months)
Net gains / (losses) on disposals of operating assets or businesses241 344 
Amvuttra licensing income398 120 
Other161 69 
Total other operating income800 533 
Regeneron alliance:
(i) (Profit)/loss sharing(3,486)(2,475)
(ii) Additional profit share for development cost from Regeneron594 494 
(iii) Selling expense reimbursements to Regeneron(336)(346)
Other(208)(149)
Total other operating expenses(3,436)(2,476)